ATCC announces Ruth R. Cheng, PhD, as president & CEO. She succeeds Raymond H. Cypess, DVM, PhD, who remains on the Board of Directors as chairman.

In the 1960s, a formalin-inactivated measles vaccine (FIMV) predisposed recipients to atypical measles, an immune complex–mediated disease1,2. To identify characteristics of the immune priming ...

ATCC is a 501(c)3 nonprofit organization with headquarters in Manassas, Virginia, and a research and technology center of excellence in Gaithersburg, Maryland. Contacts.